Stereotactic body radiotherapy: a new non-invasive way to conduct pulmonary artery denervation

Stereotactic body radiotherapy: a new non-invasive way to conduct pulmonary artery denervation

BackgroundPulmonary arterial hypertension is a severe and life-threatening disease characterized by a progressive increase in pulmonary vascular resistance. Catheter-based pulmonary artery denervation (PADN) has been conducted in pulmonary arterial hypertension patients; however, if stereotactic bod...

Full description

Saved in:

Bibliographic Details
Main Authors:	Manzhen Liao, Taoyue Yao, Yonghui Xie, Shelby Kutty, Jinqiao Liu, Wei Peng, Ting Huang, Huaiyang Chen, Haoqin Fan, Zhenghui Xiao, Qiming Liu, Yunbin Xiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Medicine
Subjects:	pulmonary arterial hypertension stereotactic body radiotherapy pulmonary artery denervation sympathetic nerves acute thromboembolic pulmonary arterial hypertension
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1607638/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pulmonary artery denervation in patients with pulmonary hypertension: present state and clinical experience
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

A clinical case of radiofrequency pulmonary artery denervation for treatment of a patient with residual chronic thromboembolic pulmonary hypertension
by: D. A. Feshchenko, et al.
Published: (2019-12-01)

ENDOVASCULAR TREATMENT OF THE RESIDUAL THROMBOEMBOLIC PULMONARY HYPERTENSION AFTER PULMONARY THROMBENDARTERECTOMY WITH THE DENERVATION SYSTEM SYMPLICITY
by: B. A. Rudenko, et al.
Published: (2018-04-01)

Renal Artery Denervation as a Novel Approach to Treating Resistant Hypertension
by: Aneta Rasińska, et al.
Published: (2025-05-01)

Renal denervation: a new life of the technology
by: T. Y. Chichkova, et al.
Published: (2020-12-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

Cryoablation method for pulmonary artery sympathetic denervation in patients with pulmonary hypertension secondary to left sided heart disease: interventional technique, safety and results of the hospital phase
by: D. A. Feshchenko, et al.
Published: (2019-09-01)

New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01)

Evaluation of radiographic pulmonary artery diameter and echocardiographic pulmonary artery pressure in COPD patients in South-West Nigeria
by: Zuliat A. Awoyemi, et al.
Published: (2025-07-01)

New non-pharmaceutical methods for the treatment of resistant arterial hypertension
by: A. V. Rodionov, et al.
Published: (1970-01-01)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024-09-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)

Robot-assisted renal denervation as a new surgical approach for therapy resistant arterial hypertension
by: Sarah Rosier, et al.
Published: (2024-11-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

SYMPATHIC DENERVATION OF RENAL ARTERIES: PAST, PRESENT AND FUTURE
by: Z. Kh. Shugushev, et al.
Published: (2015-12-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

Pulmonary artery pseudoaneurysm in a young man with pulmonary hypertension on computed tomography angiography
by: Tairkhan B. Dautov, et al.
Published: (2024-12-01)

ORAL ANTICOAGULANTS IN PATIENTS WITH DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION, ASPECTS OF THE PROBLEM
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
by: Alban Todesco, et al.
Published: (2024-07-01)

The pulmonary resistance‐compliance relationship: Real or mathematical artifact?
by: Sara Hungerford, et al.
Published: (2025-05-01)

"Suffocating from the unknown". Case report
by: A. G. Saribekyan, et al.
Published: (2023-06-01)

EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Disparities in Clinical Outcomes Observed Within Electronic Health Record Data From a Statewide Cohort of Pulmonary Arterial Hypertension Patients
by: Rachel Dalton, et al.
Published: (2025-01-01)

Nymphaea pubescens Willd. extract and its flavonoid constituents vasodilate rat isolated pulmonary artery via NO-sGC-cGMP pathway
by: Teerapap Panklai, et al.
Published: (2025-02-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
by: Mark A. Colantonio, et al.
Published: (2025-01-01)

How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?
by: Michele Correale, et al.
Published: (2025-04-01)

Catheter‐Based Renal Denervation for Resistant Arterial Hypertension: 10‐Year Real‐World Follow‐Up Data
by: Sofie Brouwers, et al.
Published: (2024-12-01)

A Stepwise Approach to Computed Tomography Imaging of Pulmonary Hypertension
by: Kurian C. Eapen, et al.

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
by: E. A. Rezukhina, et al.
Published: (2021-09-01)

Clinical outcomes of pregnancy in patients with pulmonary hypertension: A single center observational study
by: Jianrong Pan, et al.
Published: (2025-04-01)

Pulmonary Hypertension in Women
by: Eunwoo Park, et al.
Published: (2024-03-01)

Effectiveness of radiofrequency renal denervation in diseases with increased sympathetic nervous system activity
by: B. A. Rudenko, et al.
Published: (2022-01-01)